Jenscare Scientific (HKG:9877) filed for European regulatory approval for its JensClip transcatheter mitral valve repair system, according to a Hong Kong bourse filing Monday.
The device is designed to treat patients with severe mitral regurgitation, a condition in which the heart's mitral valve leaks.